When was Panacea Biotec founded?

Panacea Biotec was founded in 1984.

Where is Panacea Biotec located?

Panacea Biotec is headquartered in Ambala, India. It is registered at 1584/6 M V BUILDING 1ST FLOORCHANDNI CHOWK DELHI 110006, NA, Delhi, India, 000000.

Which legal entities is Panacea Biotec associated with?

Panacea Biotec is associated with PANACEA BIOTEC PHARMA LIMITED and 1 other.

How many employees does Panacea Biotec have?

As of Aug 31, 2026, the latest employee count at Panacea Biotec is 3073.

Is Panacea Biotec a funded company?

Panacea Biotec is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round.

When was the latest funding round of Panacea Biotec?

Panacea Biotec's latest funding was a $***** Post IPO round on Apr 2019, with participation from 1 investor.

What is the annual revenue of Panacea Biotec?

Annual revenue of Panacea Biotec is between ₹500 Cr and ₹1,000 Cr as on Mar 31, 2024

Where does Panacea Biotec rank among its competitors?

Panacea Biotec ranks 20th amongst 344 active competitors, of which 22 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Abingdon Health, which secured $4.4M in Oct, 2025.

Who are the top competitors of Panacea Biotec?

Panacea Biotec's top competitors include Anthem Biosciences, Patheon and Aragen. Among them, Abingdon Health secured the most recent funding round in October, 2025.

Panacea Biotec - 2026 Company Profile, Team, Funding, Competitors & Financials

Panacea Biotec is a public company based in Ambala (India), founded in 1984 by Soshil Kumar Jain. It operates as a Developer of biosimilars, vaccines and natural products. Panacea Biotec has raised an undisclosed amount in funding. The company has 344 active competitors, including 22 funded and 99 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and Aragen.

Company Details

Panacea Biotec involved in research, manufacturing and marketing of branded pharmaceutical formulations, vaccines, biosimilars (antibodies, proteins) and natural products. The product portfolio includes prescription products in therapeutic areas like pain management, diabetes, cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines.

Website: www.panaceabiotec.com
Social
Email ID: *****@panaceabiotec.com
Registered Address: 1584/6 M V BUILDING 1ST FLOORCHANDNI CHOWK DELHI 110006, NA, Delhi, India, 000000

Key Metrics

Founded Year

1984

Location

Ambala, India

Stage

Public

Latest Funding Round

Post IPO, Apr 2019, $*****

Investors

India Resurgence Fund & 2 more

Ranked

20^th among 344 active competitors

Annual Revenue

₹500 - ₹1,000 Cr as on Mar 31, 2024

Employee Count

3,073 as on Aug 31, 2026

Similar Companies

Anthem Biosciences & 231 more

Exit Details

Public

View Panacea Biotec's full profile

Panacea Biotec is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PANACEA BIOTEC PHARMA LIMITED CIN: U24299PB2019PLC068319 , India, Active	Mar 22, 2019	₹100 - ₹500 Cr (As on Mar 31, 2025)	830 (As on Oct 31, 2024)
PANACEA BIOTEC LIMITED CIN: U24233DL1984PLC017475 , India, Inactive for e-filing	Feb 02, 1984	₹500 - ₹1,000 Cr (As on Mar 31, 2024)	1522 (As on Aug 31, 2025)

Panacea Biotec got listed on Apr 17, 1996.

Click here to take a look at Panacea Biotec's IPO in detail

Panacea Biotec has raised funding over 3 rounds. Its latest funding round was a Post IPO round on Apr 2019 for $*****. 1 investor participated in its latest round. Panacea Biotec has 3 institutional investors.

Here is the list of recent funding rounds of Panacea Biotec:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 2019	6452843	Post IPO	1757529	5617863	1684649	4978638
Sep 2011	2574977	Conventional Debt	5762491	5576014	6686039	7457979

Access funding benchmarks and valuations. Sign up today!

View details of Panacea Biotec's funding rounds and investors

The founders of Panacea Biotec is Soshil Kumar Jain.

Here are the details of Panacea Biotec's key team members:

Soshil Kumar Jain: Former Founder of Panacea Biotec.

View details of Panacea Biotec's Founder profiles and Board Members

Panacea Biotec's employee count trend

Panacea Biotec has 3,073 employees as of Aug 26. Here is Panacea Biotec's employee count trend over the years:

Uncover Panacea Biotec's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Panacea Biotec include Anthem Biosciences, Patheon and Aragen. Here is the list of Top 10 competitors of Panacea Biotec, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Anthem Biosciences 2006, Bengaluru (India), Public	Developer of integrated contract research development and manufacturing services	$35.7M	Portsmouthtechnologiestrialsunit, True North ... & 8 others	76/100
2nd	Patheon 1974, Durham (United States), Acquired	Global CDMO providing integrated drug development, clinical trials, and manufacturing services	$141M	Frazier Healthcare Partners, Audax Group & 3 others	74/100
3rd	Aragen 2001, Hyderabad (India), Series B	Provider of drug discovery, clinical development, manufacturing, and other services for small molecules	$161M	Goldman Sachs, Quadria Capital & 18 others	69/100
4th	KBI Biopharma 1996, Durham (United States), Acquired	Provider of protein formulation, process & cell line development, and cGMP services	$21M	Ballast Point Ventures, NCBiotech & 1 others	69/100
5th	Syngene 1993, Bengaluru (India), Public	Provider of contract research and manufacturing services for both small molecules and biologics	$85.9M	True North, Education Growth Partners & 9 others	66/100
6th	Abzena 2001, Cambridge (United Kingdom), Acquired	Provider of antibody discovery, cell line development, and bio analytics services	$67.1M	Imperial Innovations, Invesco Perpetual & 11 others	66/100
7th	Abingdon Health 2008, York (United Kingdom), Public	Developer of immunoassays for diagnostic purposes	$24.1M	Imperial Innovations, Mercia & 2 others	64/100
8th	Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired	Aseptic manufacturing CDMO providing fill-finish services for sterile injectables	$16.9M	Municipal Employees' Retirement System, Trout Creek Ventures ... & 5 others	59/100
9th	EirGenix 2012, Taipei (Taiwan), Public	Contract development and manufacturing organization for biologics	-	CDIB Capital Group, Taiwania Capital & 3 others	58/100
10th	Piramal Pharma Solutions 1988, Mumbai (India), Unfunded	Contract manufacturer of pharmaceutical products	-	Thecarlylegroup.fr	58/100
20th	Panacea Biotec 1984, Ambala (India), Public	Developer of biosimilars, vaccines and natural products	-	India Resurgence Fund, Department of Biotechnology ... & 1 others	62/100